About this trial
The investigators conduct a randomized, double-blind, placebo-controlled study to investigate the effects of Fermented Protaetia brevitarsis seulensis powder on Alcohol-induced Liver Disease in adults for 8 weeks.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Gamma-glutamyl transferase ranging from upper limit of reference to four times of upper limit
Disqualifiers
Abnormal liver or renal function (i.e., serum aminotransferase activity > 3 times of upper limit of reference range and serum creatinine concentrations > 1.2 mg/dL)
Diabetes (diagnosed clinically or fasting glucose level > 126 mg/dL)
History of viral hepatitis or cancer
Uncontrolled hypertension
Trial design
Parallel
Treatments tested in this trial
Fermented Protaetia brevitarsis seulensis powder group
Dietary supplementThis group takes Fermented Protaetia brevitarsis seulensis powder for 8 weeks
Placebo group
Dietary supplementThis group takes placebo for 8 weeks
Treatment groups
Trial outcomes
Primary outcomes
Concentration of Gamma-Glutamyl Transpeptidase
Gamma-Glutamyl Transpeptidase
Secondary outcomes
Concentration of Aspartate aminotransferase
Aspartate aminotransferase
Concentration of Alanine aminotransferase
Alanine aminotransferase
Fatigue Severity Scale
Fatigue Severity Scale, minimum\~maximum values (1\~7), higher scores mean a worse outcome.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.